Mivacurium chloride

Mivacurium chloride (CAS No.: 106861-44-3) is a synthetic benzylisoquinolinium class small molecule widely categorized in pharmacology research as a short acting non depolarizing neuromuscular blocking probe and is primarily used in biomedical investigation of cholinergic neurotransmission at the neuromuscular junction, where it functionally antagonizes nicotinic acetylcholine receptor mediated end plate activation to reduce acetylcholine driven depolarization and thereby suppress skeletal muscle contraction in experimental systems; within drug discovery and translational physiology workflows, it is commonly applied as a reference comparator for peripheral nicotinic receptor blockade, mechanism based assay development, and characterization of neuromuscular transmission dynamics in isolated tissue preparations, engineered muscle cell platforms, and in vivo animal studies focused on motor function and anesthesia related pharmacology, while reported activity is generally described in assay dependent nanomolar to micromolar concentration ranges for receptor level and functional inhibition endpoints, and practical concentrations or doses used in experiments typically depend on specific experimental designs, model species, exposure windows, and research objectives, with protocol optimization usually guided by readouts such as contractile force suppression, reversibility, and selectivity against other cholinergic signaling components.